Ophthalmology

Clinical stage ophthalmology pharmaceutical company OcuTerra introduced David Tanzer, MD, as its newest chief medical officer and executive vice president of clinical and medical affairs, according to a June 25 press release.

EyesNY (Saratoga Springs) opened its seventh location in Clifton Park, N.Y., according to a June 25 announcement.

Eighty-nine percent of ophthalmologists are board certified, according to Merritt Hawkins physician revenue calculator and Medscape's 2021 "Physician Compensation Report."

A survey from the American Academy of Ophthalmologists shows that more than 96 percent of ophthalmologists nationwide are vaccinated.

Three percent of ophthalmologists have a net worth of at least $5 million, according to Medscape.

Troy, Mich.-based TruVista Surgery Center joined Sunvera Group, a private equity-backed management services organization, according to a June 16 news release.

Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company.

Eye care group EyeSouth Partners introduced Kenneth Zongor as its next CFO, succeeding Jason Shafer, who will continue with the company as chief development officer, according to a June 15 press release.

Columbia University in New York City recently introduced Steven E. Rosenberg, MD, as director of pediatric ophthalmology and the Anne S. Cohen Endowed Professor of Pediatric Ophthalmology.

Ophthalmic pharmaceutical company Alimera recently added David Dyer, MD, as its chief retina specialist.